News Release

Wednesday, April 23, 2025

NIH researchers supercharge ordinary clinical device to get a better look at the back of the eye

New technique brings retina into sharper focus .

Comparison of the same patch of retina labeled with indocyanine green and visualized 3 different ways. A) Scanning laser ophthalmoscopy. B) AI-enhanced scanning laser ophthalmoscopy. C) Adaptive optics scanning laser ophthalmoscopy. Arrows highlight the same cell seen in different modalities.

Scientists at the National Institutes of Health (NIH) have leveraged artificial intelligence to transform a device designed to see tissues in the back of the eye into one sharp enough to make out individual cells. The technique provides imaging resolution that rivals the most advanced devices available and is cheaper, faster, and doesn’t require specialized equipment or expertise. The strategy has implications for early detection of disease and for the monitoring of treatment response by making what was once invisible now visible.  

“AI potentially puts next-generation imaging in the hands of standard eye clinics. It’s like adding a high-resolution lens to a basic camera.” said Johnny Tam, Ph.D., investigator at NIH’s National Eye Institute and senior author of the study report, which published in Communications Medicine.

Imaging devices, known as ophthalmoscopes, are widely used to examine the light-sensing retina in the back of the eye. A scanning laser ophthalmoscope is standard in eye clinics, but its resolution can only make out structures at the tissue level—things such as lesions, blood vessels, and the optic nerve head. Next-generation ophthalmoscopes enabled with adaptive optics—a technology that compensates for light distortion—can make out cellular features, providing greater diagnostic information. However, adaptive optics-enabled imaging is still in the experimental phase.

Tam and collaborators developed a custom AI system to digitally enhance images of a layer of tissue beneath the light-sensing photoreceptors, known as the retina’s pigmented epithelium (RPE). The first step was to teach the system to recognize image quality as poor, moderate, or good. The researchers did this by feeding the system more than 1,400 images from different areas of the retina, obtained using adaptive-optics ophthalmoscopy. Next, they fed the system corresponding images from the same retinal locations but obtained using standard ophthalmoscopy. An image sharpness test showed that AI improved clarity eightfold.

“Our system used what it learned from rating the images obtained from adaptive optics to digitally enhance images obtained with standard ophthalmoscopy,” said Tam. “It’s important to point out that the system is not creating something from nothing. Features that we see in RPE cells with standard imaging are there, they’re just unclear.”

These techniques involve injection of a dye called indocyanine green (ICG) into the bloodstream to increase contrast of anatomical features. In the eye clinic, ICG is usually used to image the blood vessels of the eye.

“Our ICG imaging strategy allows RPE cells to be quickly and routinely assessed in the clinic,” said Joanne Li, Ph.D., first author of the report and a biomedical engineer in Tam’s lab. “With AI, high quality images of the RPE cells can be obtained in a matter of seconds, using standard clinical imaging instruments.”

The RPE cells’ function is to nourish and support photoreceptors. A variety of blinding conditions first affect RPE cells, including age-related macular degeneration, vitelliform macular dystrophy, and Stargardt disease. However, RPE cells cannot be easily imaged in the clinic. AI-enhanced ICG ophthalmoscopy puts RPE imaging within reach of the typical eye clinic.##

This press release describes a basic research finding. Basic research increases our understanding of human behavior and biology, which is foundational to advancing new and better ways to prevent, diagnose, and treat disease. Science is an unpredictable and incremental process— each research advance builds on past discoveries, often in unexpected ways. Most clinical advances would not be possible without the knowledge of fundamental basic research. To learn more about basic research, visit https://www.nih.gov/news-events/basic-research-digital-media-kit.

NEI leads the federal government’s efforts to eliminate vision loss and improve quality of life through vision research…driving innovation, fostering collaboration, expanding the vision workforce, and educating the public and key stakeholders. NEI supports basic and clinical science programs to develop sight-saving treatments and to broaden opportunities for people with vision impairment. For more information, visit   https://www.nei.nih.gov.  

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

NIH…Turning Discovery Into Health^®

###